• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

将抽样和表型分型成本纳入全基因组关联研究两阶段设计的优化过程中。

Including sampling and phenotyping costs into the optimization of two stage designs for genomewide association studies.

作者信息

Müller Hans-Helge, Pahl Roman, Schäfer Helmut

机构信息

Institute of Medical Biometry and Epidemiology, University of Marburg, Marburg, Germany.

出版信息

Genet Epidemiol. 2007 Dec;31(8):844-52. doi: 10.1002/gepi.20245.

DOI:10.1002/gepi.20245
PMID:17549751
Abstract

We propose optimized two-stage designs for genome-wide case-control association studies, using a hypothesis testing paradigm. To save genotyping costs, the complete marker set is genotyped in a sub-sample only (stage I). On stage II, the most promising markers are then genotyped in the remaining sub-sample. In recent publications, two-stage designs were proposed which minimize the overall genotyping costs. To achieve full design optimization, we additionally include sampling costs into both the cost function and the design optimization. The resulting optimal designs differ markedly from those optimized for genotyping costs only (partially optimized designs), and achieve considerable further cost reductions. Compared with partially optimized designs, fully optimized two-stage designs have higher first-stage sample proportion. Furthermore, the increment of the sample size over the one-stage design, which is necessary in two-stage designs in order to compensate for the loss of power due to partial genotyping, is less pronounced for fully optimized two-stage designs. In addition, we address the scenario where the investigator is interested to gain as much information as possible, however is restricted in terms of a budget. In that we develop two-stage designs that maximize the power under a certain cost constraint.

摘要

我们提出了用于全基因组病例对照关联研究的优化两阶段设计,采用假设检验范式。为节省基因分型成本,仅在一个子样本中对完整的标记集进行基因分型(第一阶段)。在第二阶段,然后在其余子样本中对最有前景的标记进行基因分型。在最近的出版物中,提出了两阶段设计,可将总体基因分型成本降至最低。为实现完全的设计优化,我们还将抽样成本纳入成本函数和设计优化中。所得的最优设计与仅针对基因分型成本进行优化的设计(部分优化设计)显著不同,并实现了进一步的大幅成本降低。与部分优化设计相比,完全优化的两阶段设计具有更高的第一阶段样本比例。此外,对于完全优化的两阶段设计,为弥补因部分基因分型导致的效能损失而在两阶段设计中必需的样本量相对于单阶段设计的增量并不那么明显。此外,我们还探讨了研究者希望获取尽可能多的信息,但受预算限制的情况。在此,我们开发了在特定成本约束下使效能最大化的两阶段设计。

相似文献

1
Including sampling and phenotyping costs into the optimization of two stage designs for genomewide association studies.将抽样和表型分型成本纳入全基因组关联研究两阶段设计的优化过程中。
Genet Epidemiol. 2007 Dec;31(8):844-52. doi: 10.1002/gepi.20245.
2
Optimal robust two-stage designs for genome-wide association studies.全基因组关联研究的最优稳健两阶段设计。
Ann Hum Genet. 2009 Nov;73(Pt 6):638-51. doi: 10.1111/j.1469-1809.2009.00544.x.
3
Optimal two-stage genotyping designs for genome-wide association scans.用于全基因组关联研究的最优两阶段基因分型设计
Genet Epidemiol. 2006 May;30(4):356-68. doi: 10.1002/gepi.20150.
4
Optimal designs for two-stage genome-wide association studies.两阶段全基因组关联研究的最优设计
Genet Epidemiol. 2007 Nov;31(7):776-88. doi: 10.1002/gepi.20240.
5
Optimized multi-stage designs controlling the false discovery or the family-wise error rate.控制错误发现率或家族性错误率的优化多阶段设计。
Stat Med. 2008 Sep 20;27(21):4145-60. doi: 10.1002/sim.3300.
6
Optimal multistage designs--a general framework for efficient genome-wide association studies.最优多阶段设计——全基因组关联研究高效进行的通用框架
Biostatistics. 2009 Apr;10(2):297-309. doi: 10.1093/biostatistics/kxn036. Epub 2008 Dec 15.
7
Optimization of two-stage genetic designs where data are combined using an accurate and efficient approximation for Pearson's statistic.两阶段遗传设计的优化,其中使用Pearson统计量的精确有效近似值来合并数据。
Biometrics. 2006 Dec;62(4):1132-7. doi: 10.1111/j.1541-0420.2006.00583.x.
8
Flexible designs for genomewide association studies.全基因组关联研究的灵活设计
Biometrics. 2009 Sep;65(3):815-21. doi: 10.1111/j.1541-0420.2008.01174.x. Epub 2009 Jan 23.
9
Optimal and minimax three-stage designs for phase II oncology clinical trials.肿瘤学II期临床试验的最优和极小极大三阶段设计。
Contemp Clin Trials. 2008 Jan;29(1):32-41. doi: 10.1016/j.cct.2007.04.008. Epub 2007 May 6.
10
Two-stage designs applying methods differing in costs.采用成本不同的方法的两阶段设计。
Bioinformatics. 2007 Jun 15;23(12):1519-26. doi: 10.1093/bioinformatics/btm140. Epub 2007 Apr 26.

引用本文的文献

1
Robust joint analysis allowing for model uncertainty in two-stage genetic association studies.稳健的联合分析,允许在两阶段遗传关联研究中存在模型不确定性。
BMC Bioinformatics. 2011 Jan 7;12:9. doi: 10.1186/1471-2105-12-9.
2
Methodological Issues in Multistage Genome-wide Association Studies.多阶段全基因组关联研究中的方法学问题
Stat Sci. 2009 Nov 1;24(4):414-429. doi: 10.1214/09-sts288.
3
Genetic variants associated with cardiac structure and function: a meta-analysis and replication of genome-wide association data.与心脏结构和功能相关的基因变异:全基因组关联数据的荟萃分析与重复验证
JAMA. 2009 Jul 8;302(2):168-78. doi: 10.1001/jama.2009.978-a.
4
The cost effectiveness of duplicate genotyping for testing genetic association.重复基因分型用于检测基因关联性的成本效益
Ann Hum Genet. 2009 May;73(Pt 3):370-8. doi: 10.1111/j.1469-1809.2009.00516.x. Epub 2009 Mar 25.
5
Probability that a two-stage genome-wide association study will detect a disease-associated snp and implications for multistage designs.两阶段全基因组关联研究检测疾病相关单核苷酸多态性的概率及其对多阶段设计的意义。
Ann Hum Genet. 2008 Nov;72(Pt 6):812-20. doi: 10.1111/j.1469-1809.2008.00467.x. Epub 2008 Jul 24.